<?xml version="1.0" encoding="UTF-8"?>
<p>The RRV disease state varies widely between persons. This variation is readily apparent during outbreaks of the virus, wherein most persons in an infected population have asymptomatic or subclinical infection and only a few patients are substantially affected by the virus (ratio ≈3:1) (
 <xref rid="R4" ref-type="bibr">
  <italic>4</italic>
 </xref>). Among patients reporting clinical symptoms, most will recover in 4–6 weeks. However, in some cases, joint pain, muscle pain, and fatigue can persist for several months or years (
 <xref rid="R17" ref-type="bibr">
  <italic>17</italic>
 </xref>). RRV-caused EPA is characterized by arthritis, particularly in the small joints of the hands and feet. About 20%–60% of patients also have rash, fever, malaise, or a combination of these signs and symptoms (
 <xref rid="R18" ref-type="bibr">
  <italic>18</italic>
 </xref>–
 <xref rid="R21" ref-type="bibr">
  <italic>21</italic>
 </xref>). Symptoms similar to EPA occur after infection with BFV, CHIKV, Epstein-Barr virus (
 <xref rid="R22" ref-type="bibr">
  <italic>22</italic>
 </xref>), rubella virus (
 <xref rid="R23" ref-type="bibr">
  <italic>23</italic>
 </xref>), and parvovirus B19 (
 <xref rid="R24" ref-type="bibr">
  <italic>24</italic>
 </xref>). BFV co-circulates with RRV; ≈1,600 cases of BFV infection are reported each year in Australia (
 <xref rid="R1" ref-type="bibr">
  <italic>1</italic>
 </xref>,
 <xref rid="R20" ref-type="bibr">
  <italic>20</italic>
 </xref>). Although transmission of CHIKV does not occur in Australia, clinical infections have been reported in travelers returning to Australia from endemic areas (
 <xref rid="R25" ref-type="bibr">
  <italic>25</italic>
 </xref>,
 <xref rid="R26" ref-type="bibr">
  <italic>26</italic>
 </xref>).
</p>
